中外製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/02/18 | 7,350 | 7,423 | 7,217 | 7,404 | +17 | +0.2% | 1,315,100 |
| 2025/02/17 | 7,297 | 7,418 | 7,273 | 7,387 | +136 | +1.9% | 1,359,500 |
| 2025/02/14 | 7,216 | 7,266 | 7,190 | 7,251 | -4 | -0.1% | 2,066,900 |
| 2025/02/13 | 7,075 | 7,284 | 7,054 | 7,255 | +280 | +4% | 1,938,100 |
| 2025/02/12 | 7,030 | 7,084 | 6,939 | 6,975 | -5 | -0.1% | 2,670,500 |
| 2025/02/10 | 6,909 | 6,995 | 6,851 | 6,980 | +58 | +0.8% | 1,765,200 |
| 2025/02/07 | 6,839 | 6,941 | 6,764 | 6,922 | +167 | +2.5% | 2,438,600 |
| 2025/02/06 | 6,724 | 6,938 | 6,700 | 6,755 | +130 | +2% | 2,315,600 |
| 2025/02/05 | 6,653 | 6,713 | 6,589 | 6,625 | -28 | -0.4% | 1,394,300 |
| 2025/02/04 | 6,820 | 6,858 | 6,589 | 6,653 | -47 | -0.7% | 1,767,200 |
| 2025/02/03 | 6,594 | 6,822 | 6,517 | 6,700 | -34 | -0.5% | 2,719,900 |
| 2025/01/31 | 6,566 | 6,809 | 6,489 | 6,734 | +368 | +5.8% | 4,183,500 |
| 2025/01/30 | 6,436 | 6,471 | 6,288 | 6,366 | -14 | -0.2% | 1,871,600 |
| 2025/01/29 | 6,399 | 6,472 | 6,357 | 6,380 | -14 | -0.2% | 1,702,900 |
| 2025/01/28 | 6,471 | 6,485 | 6,378 | 6,394 | -78 | -1.2% | 1,801,000 |
| 2025/01/27 | 6,580 | 6,620 | 6,455 | 6,472 | -31 | -0.5% | 2,296,300 |
| 2025/01/24 | 6,575 | 6,622 | 6,440 | 6,503 | -63 | -1% | 2,285,200 |
| 2025/01/23 | 6,580 | 6,609 | 6,488 | 6,566 | -47 | -0.7% | 1,507,300 |
| 2025/01/22 | 6,674 | 6,714 | 6,588 | 6,613 | +43 | +0.7% | 1,364,700 |
| 2025/01/21 | 6,685 | 6,685 | 6,551 | 6,570 | -120 | -1.8% | 1,125,200 |
| 2025/01/20 | 6,565 | 6,736 | 6,543 | 6,690 | +67 | +1% | 1,745,800 |
| 2025/01/17 | 6,561 | 6,632 | 6,495 | 6,623 | +5 | +0.1% | 1,304,300 |
| 2025/01/16 | 6,780 | 6,785 | 6,608 | 6,618 | -96 | -1.4% | 1,528,000 |
| 2025/01/15 | 6,836 | 6,890 | 6,611 | 6,714 | -86 | -1.3% | 2,116,200 |
| 2025/01/14 | 6,750 | 6,918 | 6,745 | 6,800 | +63 | +0.9% | 2,252,300 |
| 2025/01/10 | 6,836 | 6,887 | 6,582 | 6,737 | -217 | -3.1% | 3,520,500 |
| 2025/01/09 | 6,817 | 6,960 | 6,789 | 6,954 | +237 | +3.5% | 1,814,600 |
| 2025/01/08 | 6,828 | 6,834 | 6,696 | 6,717 | -136 | -2% | 1,903,200 |
| 2025/01/07 | 6,840 | 6,877 | 6,791 | 6,853 | +6 | +0.1% | 1,808,200 |
| 2025/01/06 | 7,002 | 7,010 | 6,764 | 6,847 | -152 | -2.2% | 2,428,900 |
| 2024/12/30 | 7,117 | 7,121 | 6,975 | 6,999 | -106 | -1.5% | 1,680,800 |
| 2024/12/27 | 6,980 | 7,158 | 6,973 | 7,105 | +159 | +2.3% | 1,940,100 |
| 2024/12/26 | 6,923 | 6,973 | 6,910 | 6,946 | -28 | -0.4% | 1,174,200 |
| 2024/12/25 | 6,960 | 6,974 | 6,903 | 6,974 | +54 | +0.8% | 1,552,200 |
| 2024/12/24 | 6,897 | 6,978 | 6,885 | 6,920 | +38 | +0.6% | 901,900 |
| 2024/12/23 | 6,821 | 6,933 | 6,750 | 6,882 | +232 | +3.5% | 1,785,600 |
| 2024/12/20 | 6,802 | 6,825 | 6,650 | 6,650 | -52 | -0.8% | 2,700,400 |
| 2024/12/19 | 6,680 | 6,785 | 6,673 | 6,702 | -111 | -1.6% | 1,523,600 |
| 2024/12/18 | 6,976 | 6,976 | 6,796 | 6,813 | -188 | -2.7% | 2,357,600 |
| 2024/12/17 | 6,860 | 7,025 | 6,840 | 7,001 | +232 | +3.4% | 2,165,900 |
| 2024/12/16 | 6,610 | 6,769 | 6,572 | 6,769 | +175 | +2.7% | 1,618,300 |
| 2024/12/13 | 6,712 | 6,772 | 6,588 | 6,594 | -176 | -2.6% | 2,665,400 |
| 2024/12/12 | 6,784 | 6,834 | 6,745 | 6,770 | +33 | +0.5% | 1,872,600 |
| 2024/12/11 | 6,702 | 6,771 | 6,652 | 6,737 | ±0 | ±0% | 1,736,300 |
| 2024/12/10 | 6,850 | 6,854 | 6,692 | 6,737 | -68 | -1% | 2,092,800 |
| 2024/12/09 | 6,726 | 6,809 | 6,700 | 6,805 | +76 | +1.1% | 1,707,000 |
| 2024/12/06 | 6,800 | 6,875 | 6,708 | 6,729 | -36 | -0.5% | 1,398,200 |
| 2024/12/05 | 6,800 | 6,829 | 6,726 | 6,765 | -3 | ±0% | 1,254,400 |
| 2024/12/04 | 6,845 | 6,864 | 6,746 | 6,768 | -2 | ±0% | 1,461,900 |
| 2024/12/03 | 6,737 | 6,795 | 6,706 | 6,770 | +165 | +2.5% | 2,677,100 |
51～
100
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「中外薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 中外薬 | 862,000円 | +1.7% | +5.0% | 2.90% | 34.60倍 | 7.46倍 |
|
ロシュ傘下で成長続ける異色の医薬品大手。抗体・バイオで先行、抗がん剤、骨・関節領域に強い |
| 第一三共 | 370,200円 | +6.0% | +4.0% | 2.11% | 22.98倍 | 4.25倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
| 武 田 | 441,900円 | +7.7% | +206.9% | 4.44% | 59.10倍 | 1.00倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位１０強入り |
| 大塚ＨＤ | 769,700円 | +2.2% | +10.2% | 1.56% | 14.78倍 | 1.49倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界９０カ所に工場 |
| アステラス薬 | 145,800円 | +0.9% | +380.2% | 5.35% | 20.08倍 | 1.72倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
市場注目の銘柄
チャート関連のコラム
